v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Apr. 04, 2025
Mar. 29, 2024
Income Statement [Abstract]    
Net sales $ 558,834 $ 516,266
Cost of sales 226,605 218,370
Gross profit 332,229 297,896
Selling, general and administrative expense 269,019 255,691
Research and development expense 28,528 23,377
Amortization of acquired intangibles 41,812 40,931
Purchase of royalty interest 35,777 0
Restructuring and other charges 3,862 12,911
Operating loss (46,769) (35,014)
Interest expense, net 9,188 19,996
Other expense, net 1,392 24,235
Loss from continuing operations before income taxes (57,349) (79,245)
Income tax benefit (1,769) (7,404)
Net loss from continuing operations (55,580) (71,841)
Loss from discontinued operations, net of taxes (125) 0
Net loss (55,705) (71,841)
Less: net income attributable to noncontrolling interest from continuing operations - net of taxes 261 157
Net loss attributable to Enovis Corporation $ (55,966) $ (71,998)
Earnings Per Share, Basic [Abstract]    
Net income (loss) per share, continuing operations, basic (in usd per share) $ (0.98) $ (1.32)
Net income (loss) per share, continuing operations, diluted (in usd per share) (0.98) (1.32)
Net income (loss) per share, discontinued operations, basic (in usd per share) 0 0
Net income (loss) per share, discontinued operations, diluted (in usd per share) 0 0
Net income (loss) per share, consolidated, basic (in usd per share) (0.98) (1.32)
Net income (loss) per share, consolidated, diluted (in usd per share) $ (0.98) $ (1.32)